Science Explorer Back to mapMap
Discussion
Nonprofit · Cheltenham · United Kingdom

WellChild

wellchild.org.ukROR OpenAlex
Research works
6
▼ 49% vs 2018-21
Citations
87
13.9 per fractional work
Top-10% rate
67.1%
all institutions 10.0%
Open access
39%
world 40%
International
22%
world 18%
WellChild

Not ranked overall: WellChild is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does WellChild work in?

In all years, 84% of research at WellChild is in Health Sciences, 16% in Life Sciences. Its largest fields are Health Professions (44%), Medicine (39%), Biochemistry, Genetics and Molecular Biology (8%). It does 1.9× the world's share of Health Sciences.

Health Sciences: 5 fractional works · 84.4% of its workHealth Professions: 3 fractional works · 43.5% of its workGeneral Health Professions: 2 fractional works · 26.6% of its workSpeech and Hearing: 1 fractional works · 16.9% of its workMedicine: 2 fractional works · 38.8% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 5.1% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 4.9% of its workRheumatology: 0 fractional works · 4.5% of its workGenetics: 0 fractional works · 4.1% of its workNephrology: 0 fractional works · 3.8% of its workPhysiology: 0 fractional works · 3.2% of its workEpidemiology: 0 fractional works · 2.7% of its workHematology: 0 fractional works · 2.4% of its workPathology and Forensic Medicine: 0 fractional works · 1.8% of its workPulmonary and Respiratory Medicine: 0 fractional works · 1.6% of its workHepatology: 0 fractional works · 1.4% of its workInfectious Diseases: 0 fractional works · 1.1% of its workTransplantation: 0 fractional works · 1.0% of its workSurgery: 0 fractional works · 0.8% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.5% of its workNursing: 0 fractional works · 2.1% of its workNutrition and Dietetics: 0 fractional works · 2.1% of its workLife Sciences: 1 fractional works · 15.6% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 7.7% of its workClinical Biochemistry: 0 fractional works · 4.0% of its workBiochemistry: 0 fractional works · 1.8% of its workGenetics: 0 fractional works · 1.0% of its workMolecular Biology: 0 fractional works · 1.0% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 7.0% of its workPharmacology: 0 fractional works · 7.0% of its workImmunology and Microbiology: 0 fractional works · 1.0% of its workImmunology: 0 fractional works · 1.0% of its workALL ITS WORKWellChild6fractional works, all years
Life Sciences16%Health Sciences84%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 2 domains and 6 fields, with their numbers
    1. Health Professions343.5%
    2. Medicine238.8%
    3. Nursing02.1%
    1. Biochemistry, Genetics and Molecular Biology07.7%
    2. Pharmacology, Toxicology and Pharmaceutics07.0%
    3. Immunology and Microbiology01.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from WellChild?

The most cited paper from WellChild is "Biomarkers of rapid chronic kidney disease progression in type 2 diabetes" (Helen C. Looker, Marco Colombo, Sibylle Hess et al., 2015), with 158 citations. Next come "Newborn screening for sickle cell disease in Europe: recommendations from a Pan‐European Consensus Conference" (153) and "Guidance on clinical research involving infants, children and young people: an update for researchers and research ethics committees" (79).

Most cited papers
#PaperReleasedCitations
1 Biomarkers of rapid chronic kidney disease progression in type 2 diabetes Helen C. Looker, Marco Colombo, Sibylle Hess et al. · Kidney International Open access 22 Jul 2015 158
2 Newborn screening for sickle cell disease in Europe: recommendations from a Pan‐European Consensus Conference Stephan Lobitz et al. · British Journal of Haematology Open access 18 Oct 2018 153
3 Guidance on clinical research involving infants, children and young people: an update for researchers and research ethics committees Neena Modi, J. Vohra, Jennifer Preston et al. · Archives of Disease in Childhood Open access 9 Jun 2014 79
4 Micronutrients in critically ill patients with severe acute kidney injury – a prospective study Marlies Ostermann, Jennifer A. Summers, Katie Lei et al. · Scientific Reports Open access 30 Jan 2020 77
5 Understanding the role of SGLT2 inhibitors in glycogen storage disease type Ib: the experience of one UK centre Rebecca Halligan, R. Neil Dalton, Charles Turner et al. · Orphanet Journal of Rare Diseases Open access 12 May 2022 34
All 27 most cited papers, with filters and sorting

Which research topics does WellChild publish most on?

By volume in 2022-now: Glycogen Storage Diseases and Myoclonus, Lysosomal Storage Disorders Research, Coagulation, Bradykinin, Polyphosphates, and Angioedema and Biosimilars and Bioanalytical Methods.

Glycogen Storage Disease…0Glycogen Storage Diseases and Myoclonus: 0 fractional worksLysosomal Storage Disord…0Lysosomal Storage Disorders Research: 0 fractional worksCoagulation, Bradykinin,…0Coagulation, Bradykinin, Polyphosphates, and Angioedema: 0 fractional worksBiosimilars and Bioanaly…0Biosimilars and Bioanalytical Methods: 0 fractional worksDialysis and Renal Disea…0Dialysis and Renal Disease Management: 0 fractional worksErythropoietin and Anemia Treatment: 0 fractional works
RheumatologyPhysiologyGeneticsImmunology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Glycogen Storage Diseases and Myoclonus Rheumatology 0 works
  2. 2 Lysosomal Storage Disorders Research Physiology 0 works
  3. 3 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 0 works
  4. 4 Biosimilars and Bioanalytical Methods Immunology 0 works
  5. 5 Dialysis and Renal Disease Management Nephrology 0 works
  6. 6 Erythropoietin and Anemia Treatment Hematology 0 works
  7. 7 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  8. 8 COVID-19 Clinical Research Studies Infectious Diseases 0 works
  9. 9 SARS-CoV-2 detection and testing Infectious Diseases 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available38.8%not open61.2%

World: 40% of research is openly available.

with international co-authors21.5%domestic only78.5%

World: 18% is written across borders.

How has WellChild's research output changed?

Output in 2022-2025 was 49% lower than in 2018-2021.

20002005201020152020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is WellChild as a percentage of every work published that year, 0.0000033% in 2021.

0.000020%0.000040%0.000060%WellChild0.000014% in 2022200020102020

Fractional works of WellChild over all fractional works that year. How the balance of science has shifted.

Other research institutions in Cheltenham

All research institutions in Cheltenham

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about WellChild. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.